| |
| |
|
| Insider
Information: |
Thomas Frank E |
| Relationship: |
Director |
| City: |
Ann Arbor |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
175,195 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,959,531 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
175,195 |
|
|
| Total
Value |
$1,959,531 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
President & COO |
2017-02-23 |
138,195 |
2012-02-01 |
0 |
Premium* |
|
|
Orchard Therapeutics Plc |
ORTX |
|
2024-01-24 |
0 |
|
0 |
Premium* |
|
|
Spero Therapeutics Inc |
SPRO |
|
2023-10-05 |
35,000 |
2022-09-15 |
0 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Director |
2024-02-14 |
2,000 |
2024-02-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LRMR |
Larimar Therapeutics Inc |
Director |
– • – |
2024-02-14 |
4 |
B |
$11.00 |
$22,000 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| ORTX |
Orchard Therapeutics Plc |
See Remarks |
• – – |
2024-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(92,081) |
0 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
|
– • – |
2023-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
35,000 |
0 |
- |
|
| ORTX |
Orchard Therapeutics Plc |
See Remarks |
• – – |
2023-03-10 |
4 |
OE |
$0.46 |
$9,182 |
D/D |
20,000 |
92,081 |
0 |
- |
|
| ORTX |
Orchard Therapeutics Plc |
See Remarks |
• – – |
2023-02-09 |
4 |
OE |
$0.46 |
$9,182 |
D/D |
20,000 |
72,081 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
Director |
– • – |
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| ORTX |
Orchard Therapeutics Plc |
See Remarks |
• – – |
2022-04-01 |
4 |
B |
$0.75 |
$7,474 |
D/D |
10,000 |
52,081 |
2.74 |
- |
|
| ORTX |
Orchard Therapeutics Plc |
See Remarks |
• – – |
2021-01-29 |
4 |
OE |
$2.44 |
$24,400 |
D/D |
10,000 |
42,081 |
0 |
- |
|
| ORTX |
Orchard Therapeutics Plc |
See Remarks |
• – – |
2021-01-11 |
4 |
D |
$6.72 |
$24,904 |
D/D |
(3,706) |
32,081 |
0 |
- |
|
| ORTX |
Orchard Therapeutics Plc |
See Remarks |
• – – |
2021-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,667 |
35,787 |
0 |
- |
|
| ORTX |
Orchard Therapeutics Plc |
See Remarks |
• – – |
2020-06-11 |
4 |
OE |
$2.44 |
$24,400 |
D/D |
10,000 |
25,120 |
0 |
- |
|
| ORTX |
Orchard Therapeutics Plc |
See RemarksOfficer |
• – – |
2020-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,120 |
|
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & COO |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
138,195 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & COO |
• – – |
2016-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
114,195 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & COO |
• – – |
2016-02-29 |
4 |
D |
$26.28 |
$13,534 |
D/D |
(515) |
97,195 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & COO |
• – – |
2016-02-27 |
4 |
D |
$27.01 |
$12,371 |
D/D |
(458) |
97,710 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & COO |
• – – |
2016-02-26 |
4 |
D |
$27.01 |
$237,094 |
D/D |
(8,778) |
98,168 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & COO |
• – – |
2015-08-20 |
4 |
D |
$61.71 |
$145,821 |
D/D |
(2,363) |
106,946 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & COO |
• – – |
2015-08-05 |
4 |
AS |
$66.85 |
$1,002,750 |
D/D |
(15,000) |
109,309 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & COO |
• – – |
2015-08-05 |
4 |
OE |
$14.91 |
$223,650 |
D/D |
15,000 |
124,309 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & COO |
• – – |
2015-06-04 |
4 |
S |
$69.27 |
$1,389,318 |
D/D |
(20,000) |
109,309 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, Chief Operating Officer |
• – – |
2015-03-03 |
4 |
D |
$49.70 |
$212,666 |
D/D |
(4,279) |
129,309 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, Chief Operating Officer |
• – – |
2015-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
133,588 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, Chief Operating Officer |
• – – |
2014-12-17 |
4 |
D |
$40.49 |
$285,293 |
D/D |
(7,046) |
121,088 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, Chief Operating Officer |
• – – |
2014-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
128,134 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
